Target Market Focus on athletic programs and military organizations that require real-time concussion assessment on the field or in the battlefield. Partnerships with collegiate, professional sports teams, and defense contractors could provide rapid validation and field deployments for NoMo Diagnostics.

Early Field Deployment Leverage the mobile qEEG with telemetry to offer on-site concussion triage services to sports teams and military units, enabling immediate medical decisions and reducing downstream costs associated with unmanaged injuries.

Strategic Partnerships Explore collaborations with universities, translational research partnerships, and healthcare manufacturers to co-develop and co-market the miniaturized qEEG biosensor, accelerating product adoption and credibility in clinical and field settings.

Funding & Validation Highlight the technology’s Columbia University incubator lineage and Coulter Foundation support to enhance credibility with investors and prospective customers, while seeking pilot programs that demonstrate real-world impact and ROI.

Pricing & Access Position the solution as a scalable telemetry-enabled device suitable for teams of varying sizes and budgets, and offer tiered models or subscription services for ongoing monitoring, data analytics, and support to broaden market reach.